EXTRA: In Praise of Maintenance (Update)
16 September 2024 - 42 minsWe revisit an episode from 2016 that asks: Has our culture’s obsession with innovation led us to neglect the fact that things also need to be taken care of?
SOURCES:Martin Casado, general partner at Andreessen Horowitz.Ruth Schwartz Cowan, professor emerita of history and sociology of science at University of Pennsylvania.Edward Glaeser, professor of economics at Harvard University.Chris Lacinak, founder and president of AVPreserve.Andrew Russell, provost of SUNY Polytechnic Institute.Lawrence Summers, professor and president emeritus of Harvard University; former Secretary of the Treasury and former director of the National Economic Council.Lee Vinsel, professor of science, technology,...
Series Episodes
664. Are Thousands of Medical Cures Hiding in Plain Sight?
Existing drugs can sometimes be repurposed to treat rare diseases. But making that match can be hard — and the financial incentives are weak. Guest host Steve Levitt tries to solve the puzzle.
51 mins
20 February Finished
All You Need Is Nudge (Update)
When Richard Thaler first published Nudge, the world was just starting to believe in his brand of behavioral economics. In this 2021 episode, we ask: How has nudge theory held up in the face of a global financial meltdown, a pandemic, and other existential crises?
57 mins
18 February Finished
663. Is Weed a Performance-Enhancing Drug?
The science says no, at least not in the athletic sense. But the psychic benefits can be large — just ask former N.F.L. star Ricky Williams. He says athletes should consider cannabis a healing drug, not a party drug. Even the N.F.L. is starting to agree. (Part two of a two-part series.)
50 mins
13 February Finished
662. If You’re Not Cheating, You’re Not Trying
In sports, the rules are meant to be sacrosanct. But when it comes to performance-enhancing drugs, the slope is super-slippery. (Part one of a two-part series.)
52 mins
6 February Finished
Why Don’t Running Backs Get Paid Anymore? (Update)
They used to be the N.F.L.’s biggest stars, with paychecks to match. Now their salaries are near the bottom, and their careers are shorter than ever. In this updated episode from 2025, we speak with an analytics guru, an agent, an economist, and some former running backs to understand why.
58 mins
4 February Finished
661. Can A.I. Save Your Life?
For 50 years, the healthcare industry has been trying (and failing) to harness the power of artificial intelligence. It may finally be ready for prime time. What will this mean for human doctors — and the rest of us? (Part four of “The Freakonomics Radio Guide to Getting Better.”)
1 hour
30 January Finished
